Background and study aim: The establishment of precise and valid diagnostic criteria is important for any disease. We determined the interobserver reliability in the endoscopic diagnosis and grading of Barrett’s esophagus.
Patients and methods: Video clips of endoscopy in 21 patients with/without Barrett’s esophagus were used for training (n = 3) and for diagnosis/grading (n = 18) of Barrett’s esophagus by endoscopists from seven hospitals in Asia. Barrett’s esophagus was graded using the Prague C & M Criteria whereby the circumferential extent of the Barrett’s segment (C value), maximum extent of Barrett’s segment (M value), location of the gastroesophageal junction, and location of the diaphragmatic hiatus were scored. The intraclass correlation coefficients (ICC) were calculated as a measure of interobserver reliability.
Results: A total of 34 endoscopists participated. ICC values for the scores of the C value, M value, location of the gastroesophageal junction, and location of the diaphragmatic hiatus were: 0.92 (95 % confidence interval [CI] 0.88 – 0.97), 0.94 (95 %CI 0.90 – 0.98), 0.86 (95 %CI 0.78 – 0.94), and 0.81 (95 %CI 0.71 – 0.92), respectively, indicating excellent interobserver agreement. The differences in region/country, endoscopists’ experience, case volume of participating centers, or primary practice type had no significant effect on the reliability. The ICC values for recognition of Barrett’s esophagus of ≥ 1 cm were 0.90 (95 %CI 0.80 – 1.00) and 0.92 (95 %CI 0.87 – 0.98) for the C and M values, respectively, whereas the corresponding ICC values for Barrett’s segment of < 1 cm were 0.18 (95 %CI 0.03 – 0.32) and 0.21 (95 %CI 0.00 – 0.51), respectively.
Conclusions: Despite the uncommon occurrence of Barrett’s esophagus in Asia, our endoscopists exhibited excellent agreement in the endoscopic diagnosis and grading of Barrett’s esophagus using the Prague C & M Criteria. However, in view of the low interobserver reliability in recognizing Barrett’s segments of < 1 cm, future studies in Asia should take this into account when selecting the study population.
References
1
Sandler R S, Everhart J E, Donowitz M. et al .
The burden of selected digestive diseases in the United States.
Gastroenterology.
2002;
122
1500-1511
2
Botterweck A A, Schouten L J, Volovics A. et al .
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.
Int J Epidemiol.
2000;
29
645-654
3
Fléjou J F.
Barrett’s oesophagus: from metaplasia to dysplasia and cancer.
Gut.
2005;
54 Suppl 1
i6-i12
4
Ho K Y.
Gastroesophageal reflux disease in Asia: a condition in evolution.
J Gastroenterol Hepatol.
2008;
23
716-722
5
Fernandes M L, Seow A, Chan Y H, Ho K Y.
Opposing trends in incidence of esophageal squamous cell carcinoma and adenocarcinoma in a multi-ethnic Asian country.
Am J Gastroenterol.
2006;
101
1430-1436
6
Yee Y K, Cheung T K, Chan A O. et al .
Decreasing trend of esophageal adenocarcinoma in Hong Kong.
Cancer Epidemiol Biomarkers Prev.
2007;
16
2637-2640
7
Kusano C, Gotoda T, Khor C J. et al .
Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan.
J Gastroenterol Hepatol.
2008;
23
1662-1665
8
Goh K L, Wong H T, Lim C H, Rosaida M S.
Time trends in peptic ulcer, erosive reflux oesophagitis, gastric and oesophageal cancers in a multiracial Asian population.
Aliment Pharmacol Ther.
2009;
29
774-780
9
Chung J W, Lee G H, Choi K S. et al .
Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert’s classification.
Dis Esophagus.
2009;
22
676-681
10
Chen M J, Lee Y C, Chiu H M. et al .
Time trends of endoscopic and pathological diagnoses related to gastroesophageal reflux disease in a Chinese population: eight years single institution experience.
Dis Esophagus.
2010;
23
201-207
11
Lu C L, Lang H C, Luo J C. et al .
Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan.
Cancer Causes Control.
2010;
21
269-274
12
Wu J C, Mui L M, Cheung C M. et al .
Obesity is associated with increased transient lower esophageal sphincter relaxation.
Gastroenterology.
2007;
132
883-889
13
Moki F, Kusano M, Mizuide M. et al .
Association between reflux oesophagitis and features of the metabolic syndrome in Japan.
Aliment Pharmacol Ther.
2007;
26
1069-1075
14
Chung S J, Kim D, Park M J. et al .
Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups.
Gut.
2008;
57
1360-1365
15
Lee Y C, Yen A M, Tai J J. et al .
The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease.
Gut.
2009;
58
174-181
16 Asian Barrett’s Consortium Web Site. Asian Barrett’s Consortium’s statement concerning its research objectives and plans. http://dceg.cancer.gov/newsletter/nov08/article_08_EsophagealDiseasesConsortium.shtml; Publication date: Oct 5, 2009
17
Armstrong D, Bennett J R, Blum A L. et al .
The endoscopic assessment of esophagitis: a progress report on observer agreement.
Gastroenterology.
1996;
111
85-92
18
Sharma P, Dent J, Armstrong D. et al .
The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria.
Gastroenterology.
2006;
131
1392-1399
19
Lundell L R, Dent J, Bennett J R. et al .
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification.
Gut.
1999;
45
172-180
20
Lee Y C, Lin J T, Chiu H M. et al .
Intraobserver and interobserver consistency for grading esophagitis with narrow-band imaging.
Gastrointest Endosc.
2007;
66
230-236
21
Chang C Y, Lee Y C, Lee C T. et al .
The application of Prague C and M Criteria in the diagnosis of Barrett’s esophagus in an ethnic Chinese population.
Am J Gastroenterol.
2009;
104
13-20
22
Akiyama T, Inamori M, Akimoto K. et al .
Risk factors for the progression of endoscopic Barrett’s epithelium in Japan: a multivariate analysis based on the Prague C & M Criteria.
Dig Dis Sci.
2009;
54
1702-1707
23
Hwang J K, Hong S G, Joo M K. et al .
Application of Prague C & M Criteria to endoscopic description of CLE in Korea. [Article in Korean].
Korean J Neurogastroenterol Motil.
2008;
14 Suppl 1
P10
24
Wong W M, Lam S K, Hui W M. et al .
Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese – prevalence and spectrum of the disease.
Aliment Pharmacol Ther.
2002;
16
2037-2042
25
Rosaida M S, Goh K L.
Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study.
Eur J Gastroenterol Hepatol.
2004;
16
495-501
26
Sollano J D, Wong S N, Andal-Gamutan T. et al .
Erosive esophagitis in the Philippines: a comparison between two time periods.
J Gastroenterol Hepatol.
2007;
22
1650-1655
27
Tseng P H, Lee Y C, Chiu H M. et al .
Prevalence and clinical characteristics of Barrett’s esophagus in a Chinese general population.
J Clin Gastroenterol.
2008;
42
1074-1079
28
Okita K, Amano Y, Takahashi Y. et al .
Barrett’s esophagus in Japanese patients: its prevalence, form, and elongation.
J Gastroenterol.
2008;
43
928-934
29
Chen X, Zhu L R, Hou K H.
The characteristics of Barrett’s esophagus: an analysis of 4120 cases in China.
Dis Esophagus.
2009;
22
348-353
30
Park J J, Kim J W, Kim H J. et al .
H. pylori and GERD Study Group of Korean College of Helicobacter and Upper Gastrointestinal Research. The prevalence of and risk factors for Barrett’s esophagus in a Korean population: a nationwide multicenter prospective study.
J Clin Gastroenterol.
2009;
43
907-914
31
Lee I S, Choi S C, Shim K N. et al .
Prevalence of Barrett’s esophagus remains low in the Korean population: nationwide cross-sectional prospective multicenter study.
Dig Dis Sci.
2010;
55
1932-1939
32
Amano A, Kinoshita Y.
Barrett esophagus: perspectives on its diagnosis and management in Asian populations.
Gastroenterol Hepatol.
2008;
4
45-53
33
Paris workshop on columnar metaplasia in the esophagus and the esophagogastric junction, Paris, France, December 11 – 12, 2004.
Endoscopy.
2005;
37
879-920
34 International Working Group for the Classification of Oesophagitis (IWGCO) Web Site. Interactive Prague Barrett’s C & M Criteria. http://iwgco.com/; Publication date: April 27, 2010
35
Fleiss J L, Cohen J.
The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability.
Educ Psychol Meas.
1973;
33
613-619
36
Walter S D, Eliasziw M, Donner A.
Sample size and optimal designs for reliability studies.
Stat Med.
1998;
17
101-110
37
Spechler S J.
Short and ultrashort Barrett’s esophagus – what does it mean?.
Semin Gastrointest Dis.
1997;
8
59-67
38
Derakhshan M H, Malekzadeh R, Watabe H. et al .
Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer.
Gut.
2008;
57
298-305
39
Shimoda T, Kushima R, Takizawa H.
Pathological feature of esophagogastric adenocarcinoma. [Article in Japanese].
Stomach and Intestine (Tokyo).
2009;
44
1083-1094
40
Sharma P, Morales T G, Sampliner R E.
Short segment Barrett’s segment: the need for standardization of the definition and of endoscopic criteria.
Am J Gastroenterol.
1998;
93
1033-1036
41
Fujiyama Y, Ishizuka I, Koyama S.
Histochemical diagnosis of short segment Barrett’s esophagus. [Article in Japanese].
Nippon Rinsho.
2005;
63
1420-1426
42
Amano Y, Ishimura N, Furuta K. et al .
Which landmark results in a more consistent diagnosis of Barrett’s esophagus, the gastric folds or the palisade vessels?.
Gastrointest Endosc.
2006;
64
206-211
43
Kusano C, Kaltenbach T, Shimazu T. et al .
Can Western endoscopists identify the end of the lower esophageal palisade vessels as a landmark of esophagogastric junction?.
J Gastroenterol.
2009;
44
842-846
44
Amano Y, Ishimura N, Koshino K. et al .
Endoscopic diagnosis of the esophagogastric junction. [Article in Japanese].
Stomach and Intestine (Tokyo).
2009;
44
1065-1074
45
Amano Y, Ishimura N, Furuta K. et al .
Interobserver agreement on classifying endoscopic diagnoses of nonerosive esophagitis.
Endoscopy.
2006;
38
1032-1035
46
Hongo M.
Minimal changes in reflux esophagitis: red ones and white ones.
J Gastroenterol.
2006;
41
95-99
47
Miwa H, Yokoyama T, Hori K. et al .
Interobserver agreement in endoscopic evaluation of reflux esophagitis using a modified Los Angeles classification incorporating grades N and M: a validation study in a cohort of Japanese endoscopists.
Dis Esophagus.
2008;
21
355-363
48
Wani S, Sharma P.
Endoscopic surface imaging of Barrett’s esophagus: an optimistic view.
Gastroenterology.
2007;
133
11-13
49
Corley D A, Kubo A, DeBoer J, Rumore G J.
Diagnosing Barrett’s esophagus: reliability of clinical and pathologic diagnoses.
Gastrointest Endosc.
2009;
69
1004-1010
50
Rubenstein J H.
It takes two to tango: dance steps for diagnosing Barrett’s esophagus.
Gastrointest Endosc.
2009;
69
1011-1013
51
Goda K, Tajiri H, Ikegami M. et al .
Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett’s adenocarcinoma.
Gastrointest Endosc.
2007;
65
36-46
52
Yoshida T, Shimizu Y, Kato M. et al .
Advances in endoscopic diagnosis for Barrett’s esophagus and adenocarcinoma: overview. [Article in Japanese].
Endoscopia Digestiva.
2009;
21
1185-1198
53 Chey W D, Sharma P. Emerging imaging modalities to diagnose Barrett’s esophagus. Expert insights in IBS, constipation and acid-related disorders. Bethesda, Maryland; American Gastroenterological Association 2010
K. Y. HoMD
Yong Loo Lin School of Medicine National University of Singapore
5 Lower Kent Ridge Road Singapore 65 Singapore
Fax: +65-67794112
Email: khek_yu_ho@nuhs.edu.sg